VitalikTrumpXiMuskPepeShrekMarioPacRoseETH9999Inu (ETH)

Blockworks analyst Jack Mandin posted that Ethereum still holds an absolute dominant position in the on-chain lending market, with total on-chain loans on Ethereum amounting to about $13 billion, while non-Ethereum chains have about $7 billion in loans. Over the past two years, chains such as BNB, Arbitrum, Solana, Plasma and Base have taken turns occupying the second-place spot in the market, with Base currently performing the strongest. Although the total outstanding loans across the network have declined from their peak, Ethereum has been hit more sharply, dropping more than 60%, whereas loans on non-Ethereum chains have fallen about 48%. https://t.co/TSkf5NVZpD

$ETH has closed the CME gap.

Could this mark a local bottom? https://t.co/FAYcWAR91x

Science is a $21 trillion real world asset class.

@BioProtocol currently sits on a tiny fraction of that capital.

Traditional biotech has a structural problem. Early stage molecules get stranded for years in a funding gap controlled by slow moving, centralized grant committees.

Bio Protocol's OpenLabs and its autonomous AI agents are a direct fix to that constraint.

The @peptai_ rollout shows what this looks like in practice.
> PeptAI designed a novel peptide based ADHD candidate from scratch in 24 hours.
> It ran the molecule through a multi gate validation pipeline and produced a candidate ready for wet lab testing.
> Total cost was a few thousand dollars.

OpenLabs takes proposal drafting, research, and capital allocation out of separate disconnected services and puts them into one continuous on chain workspace.

Humans and AI agents work on research together. Community voting funds execution directly.

The ecosystem is quietly building the infrastructure to bring real therapeutics to life faster and cheaper than traditional pharma. ethereum:0xcb1592591996765ec0efc1f92599a19767ee5ffa